Patents Assigned to Optimal Medicine Ltd.
  • Predicting a response to olanzapine
    Publication number: 20110223593
    Abstract: The invention relates generally to the relative effect of specific genetic polymorphisms in predicting the clinical outcome of olanzapine therapy in patients suffering from a psychiatric disease such as schizophrenia.
    Type: Application
    Filed: April 9, 2010
    Publication date: September 15, 2011
    Applicant: Optimal Medicine Ltd.
    Inventor: Maria Arranz